Basel Medical reported total assets of $15.53M and total liabilities of $10.49M for the quarter ended Dec 2025. This balance sheet covers 5 quarters of results from Dec 2023 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & EquivalentsCash & Equiv. | 1.22M | 1.44M | 2.34M | 1.04M | |
| Cash & Current Investments | 1.22M | 1.44M | 2.34M | 1.04M | |
| Receivables - NetNet Receivables | 1.48M | 5.02M | 7.29M | 2.51M | |
| Receivables - OtherOther Receivables | 0.69M | 0.16M | 10.56M | 0.10M | 0.35M |
| Receivables | 1.64M | 15.58M | 7.39M | 2.86M | |
| Inventory | 0.05M | 0.10M | 0.38M | 0.26M | |
| Current Assets | 11.95M | 14.46M | 10.21M | 10.94M | |
| Non-Current Assets | |||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.10M | 0.48M | 4.14M | 4.59M | |
| Long-Term Investments | 49.00 | 100.00 | |||
| Long-Term Deferred Tax | 0.06M | 0.08M | 0.04M | 0.04M | |
| Other Non-Current Assets | 1.59M | 1.89M | 0.03M | 0.03M | |
| Non-Current Assets | 0.10M | 0.48M | 4.14M | 5.95M | |
| Assets | 12.05M | 14.93M | 14.35M | 15.53M | |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payables | 1.90M | 2.05M | 5.05M | 2.84M | |
| Notes Payables | 2.00M | 0.49M | 1.63M | 0.89M | |
| Payables | 3.90M | 2.54M | 6.68M | 3.72M | |
| Short term Debt | 2.00M | 4.37M | 1.63M | 2.27M | |
| Current Taxes | 0.33M | 0.21M | 10.16M | 7.52M | |
| Total Current Liabilities | 5.29M | 7.81M | 5.80M | ||
| Non-Current Liabilities | |||||
| Non-Current Debt | 1.17M | 4.37M | 2.27M | 4.66M | |
| Pension | 3.08M | 6.08M | |||
| Minority Interest | 0.00M | 0.25M | |||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.10M | 0.03M | |||
| Operating Leases | 0.02M | 2.27M | 3.13M | ||
| Other Non-Current Liabilities | 0.01M | 0.01M | 0.01M | 0.01M | |
| Total Non-Current Liabilities | 1.17M | 7.66M | 2.37M | 4.69M | |
| Total Liabilities | 6.47M | 7.67M | 10.17M | 10.49M | |
| Shareholder's Equity | |||||
| Total Debt | 5.17M | 9.23M | 5.53M | 7.82M | |
| Common Equity | 5.61M | 4.18M | 5.03M | ||
| Liabilities and Shareholders Equity | 12.05M | 14.93M | 14.35M | 15.53M | |
| Retained Earnings | 5.59M | 7.27M | -3.04M | -2.84M |